Cardiff Lexington Corporation · OTC:CDIX
Cardiff Lexington — Cardiff Lexingtn — Q1 2026 Earnings Presentation
11 slides from Cardiff Lexington's earnings presentation, May 19, 2026
Slide 1: First Quarter 2026 Earnings Presentation
FIRST QUARTER 2026 EARNINGS PRESENTATION Tuesday, May 19, 2026 OTC: CDIX
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation does not constitute or form part of and should not be construed as, an offer to sell or issue or the solici tation of an offer to buy or subscribe for securities of Cardiff Lexington (the “Company”) in any jurisdiction or an inducement to enter into inves
Slide 3: Executive Summary
EXECUTIVE SUMMARY Cardiff Lexington by the Numbers First quarter ended March 31, 2026 Operational & Strategic Highlights 11 • Expanding clinical and operational Nova Ortho and Spine locations teams across Nova Ortho & Spine throughout Florida & Georgia Network $2.2 M • Upgraded to OCTQX exchange; en
Slide 4: Strong Market Presence
STRONG MARKET PRESENCE 11 Nova Ortho & Spine locations strategically positioned in population centers throughout Florida and Georgia with plans to expand to broader southeast US • Okeechobee (FL) • Tallahassee (FL) • Orlando (FL) • Fort Pierce (FL) • Madison (FL) • Chipley (FL) • Vero Beach (FL) • P
Slide 5: Synergistic Pillars for M&A Growth
SYNERGISTIC PILLARS FOR M&A GROWTH Target Strong Core Cash Acquire Accretive Assets Drive Long-Term & Flows to Current Model Sustainable Profitability Acquire, optimize, and Expand geographic Acquire and manage manage physician footprint through personal injury practice practices with strong ownersh
Slide 6: First Quarter 2026 Financial Highlights
FIRST QUARTER 2026 FINANCIAL HIGHLIGHTS Three Months Ended 3/31/26 3/31/25 Revenue $2,222,280 $2,915,567 Cost of sales $904,225 $1,075,034 Gross profit $1,318,055 $1,840,533 Gross margin 59.3% 63.1% Selling, general & administrative expense $1,164,425 $1,280,641 Total operating expenses $1,829,214 $
Slide 7: Enhanced Balance Sheet
ENHANCED BALANCE SHEET Accounts Receivable Total Assets $22.9M $30.3M $29.1M $22.1M 12.31.25 3.31.26 12.31.25 3.31.26 3.7% Increase 4.1% Increase 7
Slide 8: Proven Business Model Supports Long-Term Strategy
PROVEN BUSINESS MODEL SUPPORTS LONG- TERM STRATEGY Proven Growth & Profitability with Existing Model Demonstrated ability to drive growth and profitability in diverse economic markets and conditions Consistent Performance with Limited Working Capital Proven track record of driving return on invested
Slide 9: Q&A
we 4 CARDIFF LEXINGTON CORPORATION Q&A
Slide 10: Appendix
we 4 CARDIFF LEXINGTON CORPORATION APPENDIX
Slide 11: Reconciliation of Non-GAAP Metrics
RECONCILIATION OF NON-GAAP METRICS Three months ended 3/31/26 3/31/25 Net Income (loss) before discontinued operations $(3,092,074) $(450,777) Adjustments to reconcile net income/(loss) to EBITDA Interest 1,910,737 993,114 Taxes 0 0 Depreciation 593 3,365 Amortization 11,438 0 EBITDA $(1,169,306) $5